Dynamics Special Purpose Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DYNS research report →
Price Chart
About the company
At present, Dynamics Special Purpose Corp. does not engage in any material business operations. Its sole purpose is to execute a strategic business combination, such as a merger, capital stock exchange, acquisition of assets or stock, or a reorganization, involving one or more existing enterprises.
- CEO
- Omid C. Farokhzad
- IPO
- 2021
- HQ
- Redwood City, CA, US
Get TickerSpark's AI analysis on DYNS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $329.37M
- P/E
- -5.73
- PEG
- -0.03
- P/S
- 0.00
- P/B
- -68.77
- EV/EBITDA
- 10.72
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1539.97%
- ROIC
- -220.30%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-68,779,000
- Net Income
- $-61,438,000-16.4%
- EPS
- $-2.73+77.3%
- OCF Growth
- -4.9%
- FCF Growth
- -5.4%
- 52W High
- $10.54
- 52W Low
- $7.18
- 50D MA
- $9.76
- 200D MA
- $9.88
- Beta
- 0.00
- RSI (14)
- 4
- Avg Volume
- 57.15K
No earnings-call transcripts are available for DYNS yet.
- Free Float
- 58.7%
- Shares Outstanding
- 43.86M
- Float Shares
- 25.76M
of shares held by institutions
45 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 25, 21 | Nishar Dipchand | other | 0 |
| May 25, 21 | Nishar Dipchand | other | 112,519 |
| May 25, 21 | FLATLEY JAY T | other | 0 |
| May 25, 21 | FLATLEY JAY T | other | 112,519 |
| May 25, 21 | Chapman Rowan E | other | 0 |
| May 25, 21 | Ronaghi Mostafa | other | 0 |
| May 25, 21 | Ronaghi Mostafa | other | 5,750,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DYNS coverage
Recent articles, reports, and earnings notes.
No research on DYNS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DYNS report →Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
globenewswire.com · Jan 6
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
benzinga.com · Dec 20
Cathie Wood Makes Adjustments to Portfolio in August
gurufocus.com · Sep 13
U.S. IPO Weekly Recap And Week Ahead
seekingalpha.com · May 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.